TELO Telomir Pharmaceuticals
- 4.250
- +0.270+6.78%
- 4.250
- 0.0000.00%
Telomir Pharmaceuticals News
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Whalen Matthew Pratt
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-Q: Quarterly report
Analysis
Price Target
No Data
No Data